X

Vous n'êtes pas connecté

Articles similaires

Sorry! Image not available at this time

Top stocks to buy: Stock recommendations for today

times of india - 21/Mar 02:00

Stock market recommendations: Bajaj Broking Research recommends Zydus Lifesciences and National Aluminium stocks for today. It expects Nifty to move...

Top stocks to buy today: Stock recommendations for March 25, 2025

times of india - 25/Mar 02:00

Stock market recommendations: RBL Bank and ACC are recommended stocks to buy today by Somil Mehta of Mirae Asset Sharekhan. RBL Bank is anticipated to...

Top stocks to buy today: Stock recommendations for March 25, 2025

times of india - 25/Mar 02:00

Stock market recommendations: RBL Bank and ACC are recommended stocks to buy today by Somil Mehta of Mirae Asset Sharekhan. RBL Bank is anticipated to...

Sorry! Image not available at this time

Oracle Up 18.4% in a Year: Buy, Sell or Hold the Stock?

zacks.com - 21/Mar 12:30

Oracle shows strong cloud growth but high capex limits free cash flow. One can hold the stock if invested or wait for revenue acceleration from the...

Sorry! Image not available at this time

Oracle Up 18.4% in a Year: Buy, Sell or Hold the Stock?

zacks.com - 21/Mar 12:30

Oracle shows strong cloud growth but high capex limits free cash flow. One can hold the stock if invested or wait for revenue acceleration from the...

Sorry! Image not available at this time

CAVA Stock Falls 29% in 3 Months: Should You Buy, Sell or Hold?

zacks.com - 24/Mar 15:01

CAVA's focus on technology-driven efficiencies, customer loyalty initiatives and new market entries propel it for growth.

Sorry! Image not available at this time

Should Investors Buy, Sell or Hold PDD Stock Post Q4 Earnings Results?

zacks.com - 24/Mar 13:00

PDD's mixed Q4 results signal caution. Hold for now or wait for clearer growth indicators in 2025 as ecosystem investments weigh on margins despite...

Sorry! Image not available at this time

Exelixis Stock Rises 13.3% Year to Date: Buy, Sell or Hold?

zacks.com - 26/Mar 19:00

EXEL stock gains on the back of encouraging performance of its lead drug Cabometyx and efforts to improve shareholder value. However, the recent rally...

Sorry! Image not available at this time

Exelixis Stock Rises 13.3% Year to Date: Buy, Sell or Hold?

zacks.com - 26/Mar 19:00

EXEL stock gains on the back of encouraging performance of its lead drug Cabometyx and efforts to improve shareholder value. However, the recent rally...

Les derniers communiqués

  • Aucun élément